Category: News & Comments
Observing Array Biopharma
A number of biotech or biopharmaceutical companies have succeeded in the past couple of years in changing their statuses from clinical stage to revenues-generating firms. A number of these firms reside in the Prohost Portfolio , picked up before they...
Read More
October 31, 2018
0
Another Approval for Celgene and the First for Acceleron
FDA Approval for Celgene and Acceleron Drug REBLOZYL® The U.S. Food and Drug Administration ( FDA ) has approved Celgene’s ( CELG ) and Acceleron Pharma’s ( XLRN ) drug REBLOZYL® (luspatercept-aamt) for anemia only in adult patients with beta...
Read More
November 12, 2019
0
About Illumina's acquisition
Illumina (ILMN) and Pacific Biosciences (PACB) announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share, in an all-cash transaction. The agreement has already been approved by the board of directors of both...
Read More
November 2, 2018
0
RegenxBio: Another licensing agreement providing additional validation of its NAV platform
RegenxBio (RGNX) has granted Abeona Therapeutics (ABEO) an exclusive worldwide license to its NAV AAV9 viral vector (subject to certain non-exclusive rights previously granted for MPS IIIA) for the treatment of four diseases: Sanfilippo syndrome type A (MPS IIIA) and type B...
Read More
November 5, 2018
0
Why Vertex and CRISPR Rallied Today
Vertex Pharmaceuticals and CRISPR Therapeutics Rallied Today Vertex Pharmaceuticals ( VRTX ) and CRISPR Therapeutics ( CRSP ) announced positive, interim data from the first two patients with severe hemoglobinopathies treated with the investigational CRISPR/Cas9 gene-editing therapy CTX001 in ongoing...
Read More
November 19, 2019
0
Alnylam: Its Second RNAi Therapy Approval Boosted Savvy Investors' Trust
Alnylam Granted FDA Early Approval of GIVLAARI™ for AHP Alnylam’s ( ALNY ) stock outperformed as its subcutaneous injection GIVLAARI™ (givosiran) has been granted FDA early approval. GIVLAARI™ is created and developed for the treatment of adults with acute hepatic...
Read More
November 22, 2019
0
Jazz Pharmaceuticals has good, not bad news
In today’s news Jazz Pharmaceuticals (JAZZ) announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency for the approval of solriamfetol. Solriamfetol is a selective dopamine and norepinephrine reuptake inhibitor (DNRI) in development for treatment of excessive daytime...
Read More
November 9, 2018
0
Compugen: A Small Firm with Giant Technological Capabilities
Compugen to Present Data Update on COM701 Phase 1 Clinical Trial at the 2020 AACR Virtual Annual Meeting Compugen ( CGEN ) announced that it will present updates on its ongoing Phase 1 clinical trial evaluating COM701 , a first-in-class...
Read More
April 16, 2020
0
Why Gilead's and Moderna's Stocks Rallied Today
Gilead Sciences Gilead ( GILD ) stock soared after market hours adding $11 to the $1.90 the stock had gained during trading hours. Investors' enthusiasm was raised when very promising results came out of a clinical trial for Gilead’s drug...
Read More
April 16, 2020
0
Novartis to Acquire The Medicines Company at $85 a Share
Novartis to Acquire The Medicines Company Novartis ( NVS ) decided to buy The Medicines Company ( MDCO ) at $6.8 million. The Medicines Company’s shareholders will be getting $85 per share in cash - a 45% premium to its...
Read More
November 25, 2019
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)